A Major Milestone For Gene Editing To Treat Cancer- New Study Finds CRISPR Can Successfully Kill Cancer Cells Without an Adverse Affect on Patients

Overseen by the renowned immunologist Dr. Carl June, it showed the edited genes had a sustained ability to attack and kill tumors.

Published Feb 7, 2020

NOW
PLAYING
Clinical Trials For Cancer Patients May Be On Hold Amid Covid-19
NOW
PLAYING
Where to Access CAR T Cell Therapy
NOW
PLAYING
The New Illinois Bill that Removes Financial Barriers to Crucial Cancer Trials, Opening Them Up to More Minority Patients
NOW
PLAYING
'The Google Earth of Endometrial Cancer' -- a New, Molecular Snapshot Could Lead to Better Treatment of the Disease
NOW
PLAYING
Cancer Centers Share the Steps They're Taking to Keep Patients with Compromised Immune Systems Safe from the Coronavirus
NOW
PLAYING
Genetic Testing Is on the Rise -- Here's Why to Get It Done Through a Health Care Provider
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.